85 related articles for article (PubMed ID: 11445875)
1. Locomotion of lymphocytes towards melanoma cells treated with tumor necrosis factor in a syngeneic in vitro model.
Gutman H; Laish-Farkash A; Risin D; Pellis NR
Int J Mol Med; 2001 Aug; 8(2):199-203. PubMed ID: 11445875
[TBL] [Abstract][Full Text] [Related]
2. Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
Powell CB; Scott JH; Collins JL
Gynecol Oncol; 1998 Nov; 71(2):258-65. PubMed ID: 9826469
[TBL] [Abstract][Full Text] [Related]
3. Effect of tumor necrosis factor-alpha and interleukin-2 on spleen lymphocyte migration in mouse skin.
Sun J; Liu Z; Bi Y; Guo Z; Hua T; Ding Z
Lymphology; 1999 Dec; 32(4):166-70. PubMed ID: 10652700
[TBL] [Abstract][Full Text] [Related]
4. Effect of surgery on peripheral blood lymphocyte locomotion through type I collagen.
Gutman H; Risin D; Pollock RE; Pellis NR
Cancer; 1993 May; 71(9):2833-7. PubMed ID: 8467461
[TBL] [Abstract][Full Text] [Related]
5. Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle.
Mandik-Nayak L; Huang G; Sheehan KC; Erikson J; Chaplin DD
J Immunol; 2001 Aug; 167(4):1920-8. PubMed ID: 11489971
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
[TBL] [Abstract][Full Text] [Related]
7. In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes.
Applegate KG; Balch CM; Pellis NR
Cancer Res; 1990 Nov; 50(22):7153-8. PubMed ID: 2224850
[TBL] [Abstract][Full Text] [Related]
8. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
[TBL] [Abstract][Full Text] [Related]
9. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat.
Issekutz TB
J Immunol; 1990 Mar; 144(6):2140-6. PubMed ID: 2107253
[TBL] [Abstract][Full Text] [Related]
10. Blocking Tumor Necrosis Factor α Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma.
Bertrand F; Rochotte J; Colacios C; Montfort A; Tilkin-Mariamé AF; Touriol C; Rochaix P; Lajoie-Mazenc I; Andrieu-Abadie N; Levade T; Benoist H; Ségui B
Cancer Res; 2015 Jul; 75(13):2619-28. PubMed ID: 25977337
[TBL] [Abstract][Full Text] [Related]
11. Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth.
Qian JH; Titus JA; Andrew SM; Mezzanzanica D; Garrido MA; Wunderlich JR; Segal DM
J Immunol; 1991 May; 146(9):3250-6. PubMed ID: 1826709
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.
Fidler IJ; Bucana C
Cancer Res; 1977 Nov; 37(11):3945-56. PubMed ID: 908034
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
Roth AD; Hornicek FJ; Gerstner CG; Kirkwood JM
Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor.
Srinivasan JM; Fajardo LF; Hahn GM
J Natl Cancer Inst; 1990 Dec; 82(24):1904-10. PubMed ID: 2250311
[TBL] [Abstract][Full Text] [Related]
15. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
[TBL] [Abstract][Full Text] [Related]
16. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development.
Ettinger R; Mebius R; Browning JL; Michie SA; van Tuijl S; Kraal G; van Ewijk W; McDevitt HO
Int Immunol; 1998 Jun; 10(6):727-41. PubMed ID: 9678753
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor secreted by transformed human B lymphocytes: lack of an autocrine growth effect.
Pirisi M; Vasiliadis D; Harrison LC
Lymphokine Res; 1990; 9(1):27-33. PubMed ID: 2157923
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis.
Chopra M; Riedel SS; Biehl M; Krieger S; von Krosigk V; Bäuerlein CA; Brede C; Jordan Garrote AL; Kraus S; Schäfer V; Ritz M; Mattenheimer K; Degla A; Mottok A; Einsele H; Wajant H; Beilhack A
Carcinogenesis; 2013 Jun; 34(6):1296-303. PubMed ID: 23385062
[TBL] [Abstract][Full Text] [Related]
20. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
Ruddle NH; Bergman CM; McGrath KM; Lingenheld EG; Grunnet ML; Padula SJ; Clark RB
J Exp Med; 1990 Oct; 172(4):1193-200. PubMed ID: 2212948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
